|
|
News Breaks | | | | September 24, 2012 | | 07:51 EDT |  | CBIS | Cannabis Science initiates preclinical investigation of CS-TATI-1
Cannabis Science announced preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi’s sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis. The company is entertaining entrance into a number of agreements with academic and private sector clinical research organizations that will facilitate initial studies to demonstrate scientific merit of CSTATI-1 and CS-S/BCC-1 that will predictably translate to human studies within the coming year, as clinical options for this patient population remain limited and the etiology of both aggressive squamous/basel cell carcinomas and Kaposi’s sarcoma is poor in immune compromised populations, comparative to other skin cancers. | |
|
News For CBIS From The Last 14 Days Check below for free stories on CBIS the last two weeks. |
|
|
| There are no results for CBIS |
|
|
|
|
|
|
